OXURION news, videos and press releases - Page 3
For more news please use our advanced search feature.
OXURION - More news...
OXURION - More news...
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion Publishes First Half 2023 Results
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
- Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
- Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
